ECHO Biotech Overview
- Year Founded
-
2017
- Status
-
Private
- Employees
-
29
- Latest Deal Type
-
Series B
- Latest Deal Amount
-
$14M
- Investors
-
9
ECHO Biotech General Information
Description
Developer of scientific research services and drugs intended for exosomes technology and treatment. The company focuses on the research and clinical transformation exosome technology and combines more than ten years of basic exosome research with molecular biology, cell biology and bioinformatics technology, and has established a leading exosome research and transformation platform, providing exosomes-based scientific and technological services and innovative drugs based on exosomes as carriers, which mainly cover the fields of tumor immunity, neurology and rare diseases.
Contact Information
Website
www.echobiotech.com/index.phpCorporate Office
- Room 108, Building 1, China Resources Life Science Park
- Baoshen South Street, Daxing District
- Beijing
- China
Corporate Office
- Room 108, Building 1, China Resources Life Science Park
- Baoshen South Street, Daxing District
- Beijing
- China
ECHO Biotech Timeline
ECHO Biotech Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Later Stage VC (Series B) | 06-Nov-2025 | $14M | Completed | Generating Revenue | ||
| 7. Secondary Transaction - Private | 09-Jul-2024 | Completed | Generating Revenue | |||
| 6. Later Stage VC | 06-Dec-2023 | Completed | Generating Revenue | |||
| 5. Later Stage VC (Series A2) | 03-Mar-2023 | Completed | Generating Revenue | |||
| 4. Early Stage VC (Series A1) | 11-Jan-2022 | Completed | Generating Revenue | |||
| 3. Early Stage VC (Series A) | 22-Jul-2021 | Completed | Generating Revenue | |||
| 2. Early Stage VC | 29-Oct-2018 | Completed | Generating Revenue | |||
| 1. Seed Round | 05-Nov-2017 | Completed | Startup |
ECHO Biotech Patents
ECHO Biotech Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20250304681-A1 | Anti-rage antibody, extracellular vesicle, and preparation method and use thereof | Pending | 29-Mar-2024 | ||
| US-20250144145-A1 | Engineered psd protein, extracellular vesicle, and preparation method and use thereof | Pending | 03-Nov-2023 |
ECHO Biotech Signals
ECHO Biotech Investors (9)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Chengdu Bio-Town Investment | Government | Minority | ||
| Beihang Investment | Growth/Expansion | Minority | ||
| Qingdao Haier Venture Capital | Corporate Venture Capital | Minority | ||
| Zhongbo Capital | Growth/Expansion | Minority | ||
| Baidu Ventures | Corporate Venture Capital | Minority |
ECHO Biotech FAQs
-
When was ECHO Biotech founded?
ECHO Biotech was founded in 2017.
-
Where is ECHO Biotech headquartered?
ECHO Biotech is headquartered in Beijing, China.
-
What is the size of ECHO Biotech?
ECHO Biotech has 29 total employees.
-
What industry is ECHO Biotech in?
ECHO Biotech’s primary industry is Biotechnology.
-
Is ECHO Biotech a private or public company?
ECHO Biotech is a Private company.
-
What is ECHO Biotech’s current revenue?
The current revenue for ECHO Biotech is .
-
How much funding has ECHO Biotech raised over time?
ECHO Biotech has raised $29.5M.
-
Who are ECHO Biotech’s investors?
Chengdu Bio-Town Investment, Beihang Investment, Qingdao Haier Venture Capital, Zhongbo Capital, and Baidu Ventures are 5 of 9 investors who have invested in ECHO Biotech.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process